Revenue and Accounts Receivable

6 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenue and Accounts Receivable

Note 5. – Revenue and Accounts Receivable

Revenues by payor were as follows for the three and six months ended December 31, 2023 and 2022:

	Three Months Ended				Six Months Ended
	December 31,				December 31,
	2023		2022		2023		2022
Medicare	$	3,984	$	3,594	$	7,814	$	6,856
Medicaid		1,742		1,642		3,392		3,246
Retail and Institutional Pharmacy		1,618		2,535		3,322		4,034
Managed Care & Other Insurance		987		2,667		2,157		3,540
Self-pay		163		188		343		384
Other		16		14		37		29
Total Net Revenues	$	8,510	$	10,640	$	17,065	$	18,089

The revenues for the three months ended December 31, 2023 includes $59 of prior period sales tax refunds compared to a $2,615 increase in revenues in the three months ended December 31, 2022 as a result of a reduction in the accrued sales tax liability as described in Note 10. The revenues for six months ended December 31, 2023 includes $380 of prior period sales tax refunds, compared to $2,615 increase in revenues in the six months ended December 31, 2022 as a result of a reduction in the accrued sales tax liability as described in Note 10.

Accounts Receivable and Allowance for Doubtful Accounts

The Company adopted Financial Accounting Standards Board Accounting Standards Codification (“ASC”) Topic 326, Financial Statements – Credit Losses (“Topic 326”) with an adoption date of July 1, 2023. This standard requires a financial asset (or a group of financial assets) measured at amortized cost basis, to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial assets. The Company evaluates the valuation of accounts receivable concessions allowances based upon its historical collection trends, as well as its understanding of the nature and collectability of accounts based on their age and other

factors. The model is based on the credit losses expected to arise over the life of the asset based on the Company’s expectations as of the balance sheet date through analyzing historical customer data as well as taking into consideration current and estimated future economic trends. The Company adopted Topic 326 and determined it did not have a material financial impact.

The roll forward of the allowance for doubtful accounts for the three- and six months ended December 31, 2023 was as follows:

June 30, 2023 balance	$	532
Concession allowance expense		79
Write-offs		(203	)
September 30, 2023 balance		408
Concession allowance expense		67
Write-offs		(104	)
December 31, 2023 balance	$	371